Contact Us
Drug Search Results
More Filters [+]

Somatorelin

Alternative Names: somatorelin
Latest Update: 2023-12-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GHRH Imaging Agent

Novel Mechanism: Yes

Modality: Diagnostic Agent

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Belgium | France | Ireland | Italy | Korea | Luxembourg | Netherlands | Spain | Switzerland | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Somatorelin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Multiple Sclerosis

Phase 3: Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2008-007447-14

P4

Active, not recruiting

Multiple Sclerosis

2010-01-28

2004-002125-42

P3

Active, not recruiting

Other

None

Recent News Events

Date

Type

Title

12/01/2023

PubMed

 Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.

12/01/2021

PubMed

 Results of a 5-Year N-of-1 Growth Hormone Releasing Hormone Gene Therapy Experiment.

11/01/2020

PubMed

 The intra-individual stability of GH biomarkers IGF-I and P-III-NP in relation to GHRH administration, menstrual cycle, and hematological parameters.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions